Dashboard
1
Positive results in Sep 25
- OPERATING CASH FLOW(Y) Highest at CNY 838.62 MM
- NET SALES(Q) Highest at CNY 902.03 MM
- RAW MATERIAL COST(Y) Fallen by -13.41% (YoY)
2
With ROE of 5.81%, it has a very attractive valuation with a 1.68 Price to Book Value
3
Market Beating performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
CNY 5,095 Million (Large Cap)
29.00
NA
3.20%
-0.32
6.42%
1.08
Revenue and Profits:
Net Sales:
990 Million
(Quarterly Results - Dec 2025)
Net Profit:
111 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
28.09%
0%
28.09%
6 Months
45.23%
0%
45.23%
1 Year
61.64%
0%
61.64%
2 Years
63.44%
0%
63.44%
3 Years
39.49%
0%
39.49%
4 Years
-6.35%
0%
-6.35%
5 Years
0%
0%
0.0%
Cofoe Medical Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.66%
EBIT Growth (5y)
-8.73%
EBIT to Interest (avg)
22.90
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.36
Sales to Capital Employed (avg)
0.53
Tax Ratio
16.36%
Dividend Payout Ratio
117.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.41%
ROE (avg)
6.24%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
1.68
EV to EBIT
25.28
EV to EBITDA
14.50
EV to Capital Employed
2.02
EV to Sales
2.21
PEG Ratio
NA
Dividend Yield
2.05%
ROCE (Latest)
7.98%
ROE (Latest)
5.81%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
989.70
734.30
34.78%
Operating Profit (PBDIT) excl Other Income
144.90
114.20
26.88%
Interest
5.10
4.80
6.25%
Exceptional Items
36.00
6.90
421.74%
Consolidate Net Profit
110.80
60.40
83.44%
Operating Profit Margin (Excl OI)
88.60%
91.00%
-0.24%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 34.78% vs 0.63% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 83.44% vs 475.24% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,370.70
2,976.70
13.24%
Operating Profit (PBDIT) excl Other Income
528.00
491.00
7.54%
Interest
19.30
20.40
-5.39%
Exceptional Items
51.50
12.90
299.22%
Consolidate Net Profit
370.30
312.30
18.57%
Operating Profit Margin (Excl OI)
94.90%
104.00%
-0.91%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 13.24% vs 4.72% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 18.57% vs 23.49% in Dec 2024
About Cofoe Medical Technology Co., Ltd. 
Cofoe Medical Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






